Shanghai Hile Bio-Technology Co (SHSE:603718) Cyclically Adjusted PS Ratio: (As of Aug. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603718 Shanghai Hile Bio-Technology Co Ltd SHSE:603718
50 GF Score
Price ¥3.15
GF Value ¥4.19
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shanghai Hile Bio-Technology Co Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Shanghai Hile Bio-Technology Co  (SHSE:603718) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Shanghai Hile Bio-Technology Co Cyclically Adjusted PS Ratio Related Terms


Shanghai Hile Bio-Technology Co Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Shanghai Hile Bio-Technology Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Hile Bio-Technology Co Cyclically Adjusted PS Ratio Chart

Shanghai Hile Bio-Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 18.37 12.28 12.63

Shanghai Hile Bio-Technology Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.28 13.81 12.63 10.03 0.00

SHSE:603718 vs VRTX, REGN, MRNA: Cyclically Adjusted PS Ratio Comparison

For the Biotechnology subindustry, Shanghai Hile Bio-Technology Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Hile Bio-Technology Co Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Hile Bio-Technology Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Hile Bio-Technology Co's Cyclically Adjusted PS Ratio falls into.


SHSE:603718
50GF Score
Shanghai Hile Bio-Technology Co Ltd SHSE:603718
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Hile Bio-Technology Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Shanghai Hile Bio-Technology Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Shanghai Hile Bio-Technology Co's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.131/116.0564*116.0564
=0.131

Current CPI (Jun. 2026) = 116.0564.

Shanghai Hile Bio-Technology Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.139 102.400 0.158
201612 0.136 102.600 0.154
201703 0.117 103.200 0.132
201706 0.102 103.100 0.115
201709 0.153 104.100 0.171
201712 0.110 104.500 0.122
201803 0.090 105.300 0.099
201806 0.077 104.900 0.085
201809 0.136 106.600 0.148
201812 0.083 106.500 0.090
201903 0.126 107.700 0.136
201906 0.090 107.700 0.097
201909 0.121 109.800 0.128
201912 0.101 111.200 0.105
202003 0.088 112.300 0.091
202006 0.097 110.400 0.102
202009 0.119 111.700 0.124
202012 0.071 111.500 0.074
202103 0.157 112.662 0.162
202106 0.104 111.769 0.108
202109 0.154 112.215 0.159
202112 0.119 113.108 0.122
202203 0.132 114.335 0.134
202206 0.133 114.558 0.135
202209 0.157 115.339 0.158
202212 0.043 115.116 0.043
202303 0.100 115.116 0.101
202306 0.083 114.558 0.084
202309 0.118 115.339 0.119
202312 0.073 114.781 0.074
202403 0.189 115.227 0.190
202406 0.039 114.781 0.039
202409 0.102 115.785 0.102
202412 0.147 114.893 0.148
202503 0.113 115.116 0.114
202506 0.062 114.907 0.063
202509 0.059 115.471 0.059
202512 0.056 115.832 0.056
202603 0.075 116.303 0.075
202606 0.131 116.056 0.131

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Shanghai Hile Bio-Technology Co (SHSE:603718) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Hile Bio-Technology Co stock appears to be undervalued. The current stock price of ¥3.15 is trading 24.8% below its estimated GF Value™ of ¥4.19. GuruFocus considers Shanghai Hile Bio-Technology Co to be Modestly Undervalued.

Key valuation signals for SHSE:603718:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: ¥4.19 vs. price of ¥3.15 (24.8% below fair value)
  • GF Score™: 50/100 with 5 warning signs

No single metric tells the full story. See the SHSE:603718 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Hile Bio-Technology Co Business Description

Address Shanghai Jinhai Road 6720, Shanghai, CHN, 201403
Shanghai Hile Bio-Technology Co Ltd is a veterinary biological product manufacturer integrating research and development, production, sales, and service. The company has over 40 categories of poultry, livestock, and pets. The company provides services for the prevention of livestock diseases, improving the health of livestock and poultry, and improving the production efficiency of farmers, and is able to provide comprehensive solutions and an authoritative veterinary expert service system.
50GF Score

Get the complete analysis for SHSE:603718

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥3.15
Price
¥4.19
GF Value